Joseph Kelaghan

Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Ethan Basch, Bryce B. Reeve, Sandra A. Mitchell et al. · JNCI Journal of the National Cancer Institute · 2014 · 1.1K citations · Full text

Pharmacy, Oncology, Cancer Control +15

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

Valery T. Miller, John C. LaRosa, Vanessa M. Barnabei et al. · JAMA · 1995 · 605 citations

Medicine, Endocrinology, Pharmacology +15

Stroke and Use of Low-Dose Oral Contraceptives in Young Women

Stephen M. Schwartz, Diana B. Petitti, David S. Siscovick et al. · Stroke · 1998 · 203 citations · Full text

Medicine, Obstetrics, Preventive Medicine +11

Further data supporting that paclitaxel‐associated acute pain syndrome is associated with development of peripheral neuropathy

Brandi Reeves, Shaker R. Dakhil, Jeff A. Sloan et al. · Cancer · 2012 · 160 citations · Full text

Medicine, Oncology, Pharmacology +14

Barrier-Method Contraceptives and Pelvic Inflammatory Disease

Joseph Kelaghan · JAMA · 1982 · 143 citations

Medicine, Gynecology, Obstetrics +15